welcome
Investing.com

Investing.com

Health

Health

Shuttle Pharmaceuticals expands glioblastoma trial

Investing.com
Summary
Nutrition label

86% Informative

Shuttle Pharmaceuticals Holdings , Inc. has amended its agreement with Theradex Systems to expand a clinical trial for a potential cancer treatment.

The update includes an increase in the patient count from 15 to 16, to account for the addition of a replacement patient.

The expansion comes as the company reports an EBITDA of -$7.2 million in the last twelve months .

InvestingPro analysis suggests the stock is currently undervalued, though investors should note that the company is burning through cash.

VR Score

88

Informative language

89

Neutral language

62

Article tone

formal

Language

English

Language complexity

75

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

medium-lived

Source diversity

1

Affiliate links

no affiliate links

Small business owner?

Otherweb launches Autoblogger—a revolutionary way to bring more leads to any small business, using the power of AI.